Logo

IntegraGen Raises $9.6M in Second-Round Financing to Support Launch of Two Genetic Tests

Nov 17, 2005

NEW YORK, Nov. 17 (GenomeWeb News) - Genetic-test developer IntegraGen said today that it has completed a second round of financing worth $9.6 million to support the commercialization of its predictive tests.

 

IntegraGen said it has so far raised a total of $24 million to support test development and commercialization.

 

The firm said it plans to market a genetic test for autism in 2006, and a type-II diabetes test in 2008, with other tests slated for launch further in the future.

Breaking News
The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.